MY161451A - C-4" position substituted macrolide derivative - Google Patents

C-4" position substituted macrolide derivative

Info

Publication number
MY161451A
MY161451A MYPI2013002896A MYPI2013002896A MY161451A MY 161451 A MY161451 A MY 161451A MY PI2013002896 A MYPI2013002896 A MY PI2013002896A MY PI2013002896 A MYPI2013002896 A MY PI2013002896A MY 161451 A MY161451 A MY 161451A
Authority
MY
Malaysia
Prior art keywords
position substituted
macrolide derivative
substituted macrolide
derivative
mycoplasmas
Prior art date
Application number
MYPI2013002896A
Other languages
English (en)
Inventor
Tomohiro Sugimoto
Kenichi Kanemoto
Kou Kumura
Satoshi Yoshida
Keiji Tamura
Eiki Shitara
Naoki Sasamoto
Jun Kurosaka
Masato Hayashi
Kanako Yamamoto
Masato Kashimura
Yasunobu Ushiki
Haruhisa Ogita
Tomoaki Miura
Original Assignee
Taisho Pharmaceutical Co Ltd
Meiji Seika Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46721028&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MY161451(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Taisho Pharmaceutical Co Ltd, Meiji Seika Pharma Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Publication of MY161451A publication Critical patent/MY161451A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
MYPI2013002896A 2011-02-21 2012-02-20 C-4" position substituted macrolide derivative MY161451A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2011034578 2011-02-21

Publications (1)

Publication Number Publication Date
MY161451A true MY161451A (en) 2017-04-14

Family

ID=46721028

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2013002896A MY161451A (en) 2011-02-21 2012-02-20 C-4" position substituted macrolide derivative

Country Status (34)

Country Link
US (1) US9139609B2 (US07794700-20100914-C00152.png)
EP (1) EP2678349B1 (US07794700-20100914-C00152.png)
JP (1) JP5687777B2 (US07794700-20100914-C00152.png)
KR (1) KR20140008388A (US07794700-20100914-C00152.png)
CN (1) CN103492404B (US07794700-20100914-C00152.png)
AR (1) AR085286A1 (US07794700-20100914-C00152.png)
AU (1) AU2012222267B2 (US07794700-20100914-C00152.png)
BR (1) BR112013020118A2 (US07794700-20100914-C00152.png)
CA (1) CA2827474A1 (US07794700-20100914-C00152.png)
CL (1) CL2013002313A1 (US07794700-20100914-C00152.png)
CO (1) CO6801737A2 (US07794700-20100914-C00152.png)
CY (1) CY1117381T1 (US07794700-20100914-C00152.png)
DK (1) DK2678349T3 (US07794700-20100914-C00152.png)
ES (1) ES2566368T3 (US07794700-20100914-C00152.png)
HR (1) HRP20160252T1 (US07794700-20100914-C00152.png)
HU (1) HUE028245T2 (US07794700-20100914-C00152.png)
IL (1) IL227663A (US07794700-20100914-C00152.png)
IN (1) IN2013CN07459A (US07794700-20100914-C00152.png)
ME (1) ME02475B (US07794700-20100914-C00152.png)
MX (1) MX2013009585A (US07794700-20100914-C00152.png)
MY (1) MY161451A (US07794700-20100914-C00152.png)
NZ (1) NZ613956A (US07794700-20100914-C00152.png)
PE (1) PE20140649A1 (US07794700-20100914-C00152.png)
PL (1) PL2678349T3 (US07794700-20100914-C00152.png)
RS (1) RS54635B1 (US07794700-20100914-C00152.png)
RU (1) RU2599718C2 (US07794700-20100914-C00152.png)
SA (1) SA112330287B1 (US07794700-20100914-C00152.png)
SG (1) SG192655A1 (US07794700-20100914-C00152.png)
SI (1) SI2678349T1 (US07794700-20100914-C00152.png)
SM (1) SMT201600106B (US07794700-20100914-C00152.png)
TW (1) TWI513704B (US07794700-20100914-C00152.png)
UA (1) UA111191C2 (US07794700-20100914-C00152.png)
WO (1) WO2012115256A1 (US07794700-20100914-C00152.png)
ZA (1) ZA201305983B (US07794700-20100914-C00152.png)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5857008B2 (ja) * 2012-08-20 2016-02-10 大正製薬株式会社 C−4”位置換マクロライド誘導体を含有する医薬
CN103965273B (zh) * 2013-08-23 2016-05-25 普莱柯生物工程股份有限公司 一种大环内酯类化合物
CN105669798B (zh) * 2013-08-23 2019-07-26 普莱柯生物工程股份有限公司 一种大环内酯类化合物
CN103588833B (zh) * 2013-10-30 2016-08-17 北京科技大学 动物抗菌素泰拉霉素的制备方法
CN109748942A (zh) * 2014-05-16 2019-05-14 普莱柯生物工程股份有限公司 一种大环内酯类化合物
AR102810A1 (es) * 2014-08-18 2017-03-29 Taisho Pharmaceutical Co Ltd Derivado de macrólido sustituido en la posición c-4
WO2017142002A1 (ja) * 2016-02-17 2017-08-24 大正製薬株式会社 C-4"位置換マクロライド化合物フリー体及び塩の結晶形並びにそれらの製造方法
CN108610388B (zh) * 2016-12-12 2020-11-06 浙江京新药业股份有限公司 一种大环内酯的制备方法
CN109425666B (zh) * 2017-08-28 2022-07-08 广东东阳光药业有限公司 一种酰氯衍生物的lc-ms分析方法
US11072610B2 (en) 2018-09-12 2021-07-27 Novartis Ag Antiviral pyridopyrazinedione compounds
TW202126649A (zh) 2019-09-26 2021-07-16 瑞士商諾華公司 抗病毒吡唑并吡啶酮化合物
CN111423482B (zh) * 2020-04-26 2023-01-17 梯尔希(南京)药物研发有限公司 一种同位素标记的红霉胺的合成方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI8110592A8 (en) 1981-03-06 1996-06-30 Pliva Pharm & Chem Works Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof
US4474768A (en) 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
US5393743A (en) 1993-07-06 1995-02-28 Abbott Laboratories Erythromycin derivatives
FR2719587B1 (fr) 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
RU2144541C1 (ru) * 1995-12-08 2000-01-20 Руссель Юклаф Производные эритромицина, способ их получения, промежуточный продукт, фармацевтическая композиция
UA51730C2 (uk) 1996-09-04 2002-12-16 Ебботт Лабораторіз 6-o-заміщені кетоліди з антибактеріальною активністю, спосіб їх одержання (варіанти), фармацевтична композиція та спосіб регулювання бактеріальної інфекції у ссавців
ATE296308T1 (de) * 1996-09-04 2005-06-15 Abbott Lab 6-o-substituierte ketoliden mit antibakteriellen wirkung
US5804565A (en) 1996-09-24 1998-09-08 Taisho Pharmaceutical Co., Ltd. Erythromycin A derivatives
HN1998000074A (es) * 1997-06-11 1999-01-08 Pfizer Prod Inc Derivados de macrolidos c-4 sustituidos
US6407074B1 (en) 1997-06-11 2002-06-18 Pfizer Inc C-4″-substituted macrolide derivatives
US5972898A (en) * 1998-03-27 1999-10-26 Abbott Laboratories 3',3-N-bis-substituted macrolide LHRH antagonists
SK15162001A3 (sk) * 1999-05-24 2003-02-04 Pfizer Products Inc. Deriváty 13-metylerytromycínu
UY26964A1 (es) 2000-10-16 2002-06-20 Abbott Lab Derivados de eritromicina 6-0-sustituidos con mayor tolerancia gastrointestinal
WO2008106226A2 (en) * 2007-02-28 2008-09-04 Rib-X Pharmaceuticals, Inc. Macrolide compounds and methods of making and using the same
US20080203485A1 (en) 2007-02-28 2008-08-28 International Business Machines Corporation Strained metal gate structure for cmos devices with improved channel mobility and methods of forming the same

Also Published As

Publication number Publication date
AU2012222267B2 (en) 2016-07-07
CY1117381T1 (el) 2017-04-26
SA112330287B1 (ar) 2015-10-11
EP2678349A4 (en) 2014-07-30
RU2599718C2 (ru) 2016-10-10
JP5687777B2 (ja) 2015-03-18
SMT201600106B (it) 2016-04-29
TWI513704B (zh) 2015-12-21
CL2013002313A1 (es) 2014-08-08
MX2013009585A (es) 2014-06-05
SI2678349T1 (sl) 2016-04-29
UA111191C2 (uk) 2016-04-11
RU2013142898A (ru) 2015-03-27
SG192655A1 (en) 2013-09-30
BR112013020118A2 (pt) 2017-07-18
RS54635B1 (en) 2016-08-31
IL227663A0 (en) 2013-09-30
CA2827474A1 (en) 2012-08-30
US9139609B2 (en) 2015-09-22
IN2013CN07459A (US07794700-20100914-C00152.png) 2015-04-24
PE20140649A1 (es) 2014-06-25
TW201247693A (en) 2012-12-01
EP2678349B1 (en) 2016-01-13
NZ613956A (en) 2014-07-25
AU2012222267A1 (en) 2013-08-22
IL227663A (en) 2017-09-28
HRP20160252T1 (hr) 2016-04-22
WO2012115256A1 (en) 2012-08-30
ES2566368T3 (es) 2016-04-12
ZA201305983B (en) 2014-11-26
ME02475B (me) 2017-02-20
CO6801737A2 (es) 2013-11-29
DK2678349T3 (en) 2016-03-07
JP2014505723A (ja) 2014-03-06
EP2678349A1 (en) 2014-01-01
HUE028245T2 (en) 2016-12-28
CN103492404B (zh) 2016-09-07
AR085286A1 (es) 2013-09-18
US20140046043A1 (en) 2014-02-13
PL2678349T3 (pl) 2016-06-30
KR20140008388A (ko) 2014-01-21
CN103492404A (zh) 2014-01-01

Similar Documents

Publication Publication Date Title
MY161451A (en) C-4" position substituted macrolide derivative
MY163187A (en) Novel imidazo-oxazine compound or salt thereof
PH12015501392A1 (en) Pesticidal compositions and processes related thereto
UA107791C2 (en) Pesticidal compositions
MX351513B (es) Compuesto de alquinilbenceno 3,5-disustituido y sales del mismo.
MX346665B (es) Composiciones pesticidas y procedimientos relacionados con estas.
PH12015501394A1 (en) Pesticidal compositions and processes related thereto
MX2015008384A (es) Sistema de guia para puerta deslizante.
HK1223614A1 (zh) 抗細菌的哌啶基取代的 -二氫- 萘啶酮
IL232463A0 (en) Antibiotic history of 2-oxo-oxazolidine-3,5-diyl
PH12016502357A1 (en) Polyene macrolide derivative
PH12015501588B1 (en) Compounds and methods for treating bacterial infections
MX2015015906A (es) Mejoras en o con relacion a compuestos organicos.
MX366983B (es) Derivados de 1,5-naftiridina e inhibidores de cinasa de cremallallera de leucina embrionica materna que los contienen.
AU2012310674B2 (en) Radioactive fluorine labeled compound
MY178583A (en) Hydantoin derivative
PH12018500999A1 (en) Sodium channel blocker
PH12017500223A1 (en) C-4`` position substituted macrolide derivative
TH150792A (th) อนุพันธ์แมโครไลด์ซึ่งถูกแทนที่ที่ตำแหน่ง c-4"
Garfield For Some Time Now
IT1404205B1 (it) Sistema per l'aggancio di guide a scorrimento per ante scorrevoli di mobili.
TH146154A (th) องค์ประกอบต่อต้านแบคทีเรีย ไธมอล และทอแทลอล
UA87695U (uk) Сполука 4,5,6,7-тетрагідро-3н-2-n-(пара-метоксифенациламіно)-азепіну гідрохлорид, що має інотропну активність
CO6650412A2 (es) Proceso para la preparación de 8-alcoxi[1.2.4]triazol[1.5-c]pirimidin-2-aminas substituidas -5
GB2532584A (en) A compound, transitmycin, effective against bacterial and viral pathogens